Alyeska Investment Group, L.P. Amgen Inc Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $62.3 Million - $79.2 Million	272,182 New	272,182 $71.5 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $4.65 Million - $6.17 Million	25,540 Added 11.3%	251,646 $51 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $4.54 Million - $5.84 Million	24,018 Added 11.88%	226,106 $54.5 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $35.2 Million - $42.2 Million	202,088 New	202,088 $39.1 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.